Skip to content

A COMPARISON OF INTRAVENOUS LACOSAMIDE AND INTRAVENOUS PHENYTOIN IN ACUTE FOCAL SEIZURES â?? A RANDOMIZED CONTROLLED TRIAL

A COMPARISON OF IV LACOSAMIDE AND IV PHENYTOIN IN ACUTE FOCAL SEIZURES â?? A RANDOMIZED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052201
Enrollment
60
Registered
2023-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G400- Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

Interventions

Intervention1: IV Lacosamide and IV Phenytoin: When the patient is brought with Seizures, measures will be taken to establish and maintain a patent airway, breathing and circulation. Children who come

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children in the age group of 4 to 12 years, presenting with acute focal seizures.

Exclusion criteria

Exclusion criteria: 1. Children receiving long term antiseizure drugs. 2. Patients with clinical evidence of meningitis or sepsis. 3. Acute head injury. 4. Children having febrile seizures. 5. Children with congenital anomalies and developmental delay. 6. Children with known chronic illnesses.

Design outcomes

Primary

MeasureTime frame
No return of seizure activity for the next 24 hours.Timepoint: No return of seizure activity for the next 24 hours.

Secondary

MeasureTime frame
1. Stopping of clinical seizure activity within the first 20 mins of first intervention. 2. Adverse events to treatment in form of hypotension, respiratory depression or cardiac arrhythmias. 3. Behavioural issues such as aggression. 4. In hospital complications. 5. Neurological outcome at discharge. 6. Achievement of therapeutic drug levels.Timepoint: 24 hours

Countries

India

Contacts

Public ContactDr Deva Aravindan S

Department of Pediatrics, University College of Medical Sciences and GTB Hospital

aanju67@gmail.com9910329791

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026